Plasma Natriuretic Peptides for Community Screening for Left Ventricular Hypertrophy and Systolic Dysfunction: The Framingham Heart Study

Vasan, Ramachandran S., Benjamin, Emelia J., Larson, Martin G., Leip, Eric P., Wang, Thomas J., Wilson, Peter W. F., Levy, Daniel·2002·JAMA

Cited by (493)

Items 301–400 of 493

  1. Natriuretic Peptides and Assessment of Cardiovascular Disease Risk in Asymptomatic Persons
    Lori B. Daniels · 2010 · Current Cardiovascular Risk Reports
  2. BNP as discharge criteria for heart failure
    Mary A. Caldwell, Jill N. Howie, Kathleen Dracup · 2003 · Journal of Cardiac Failure
  3. The Measurement of Brain Natriuretic Peptide in Heart Failure
    Jill N. Howie, Mary A. Caldwell, Kathleen Dracup · 2003 · AACN Clinical Issues Advanced Practice in Acute & Critical Care
  4. Physicians and Machine-Learning Algorithm Performance in Predicting Left-Ventricular Systolic Dysfunction from a Standard 12-Lead-Electrocardiogram
    Tomer Golany, Kira Radinsky, Natalia Kofman, Ilya Litovchik, Revital Young, Antoinette Monayer, Itamar Love, Faina Tziporin, Ido Minha, Yakir Yehuda et al. · 2022 · Journal of Clinical Medicine
  5. N‐terminal Prohormone Brain Natriuretic Peptide‐proBNP Levels in Ventricular Arrhythmias in Children
    Bogusław Mazurek, Lesław Szydłowski, Grazyna Giec-Fuglewicz, Grażyna Markiewicz‐Łoskot · 2009 · Clinical Cardiology
  6. Association of N-Terminal Pro B-Type Natriuretic Peptide With Blood Pressure and Pulse Pressure in Elderly People ― A Cross-Sectional Population Study ―
    Nobuo Sasaki, Hideya Yamamoto, Ryoji Ozono, Saeko Fujiwara, Yasuki Kihara · 2018 · Circulation Journal
  7. The prognostic capacity of B-type natriuretic peptide on cognitive disorder varies by age
    Matti Hiltunen, Tuomas V. Kerola, Raimo Kettunen, Sirpa A. Hartikainen, Raimo O. Sulkava, Olli J. Vuolteenaho, Tuomo V. M. Nieminen · 2012 · Annals of Medicine
  8. Strategies to Screen for Stage B as a Heart Failure Prevention Intervention
    Margaret M. Redfield · 2012 · Heart Failure Clinics
  9. Pulmonary function and diffusion capacity are associated with pulmonary arterial systolic pressure in the general population: The Rotterdam Study
    Daan W. Loth, Lies Lahousse, Maarten J.G. Leening, Bouwe P. Krijthe, Janine F. Felix, Henning J. Gall, Albert Hofman D, Hossein Ardeschir Ghofrani, Oscar H. Franco, Bruno H. Ch. Stricker et al. · 2017 · Respiratory Medicine
  10. Left and right ventricular diastolic dysfunction in patients with early rheumatoid arthritis before prescribing disease-modifying antirheumatic therapy
    Кириллова Ирина Геннадьевна, Diana Sergeyevna Novikova, Т. В. Попкова, Yu. N. Gorbunova, E. I. Markelova, Yu. O. Korsakova, Alexander V. Volkov, E. N. Alexandrova, Alexander A. Novikov, Olga A. Fomicheva et al. · 2015 · Terapevticheskii arkhiv
  11. The Value of B-Type Natriuretic Peptide and Big Endothelin-1 for Detection of Severe Pulmonary Hypertension in Heart Transplant Candidates
    Miloš Kubánek, Ivan Málek, Josef Kautzner, Markéta Hegarová, Martin Wiendl, Petr Lupínek, L Karasová, Věra Lánská · 2005 · European Journal of Heart Failure
  12. Increased plasma concentrations of N‐terminal pro‐B‐type natriuretic peptide in patients with mild primary hyperparathyroidism
    Erik G. Almqvist, Charlotte Becker, Anne‐Greth Bondeson, Lennart Bondeson, Johan Svensson, Sven‐Eric Svensson · 2006 · Clinical Endocrinology
  13. Easy Access Echocardiography for the General Practicioner: Results from the Parkstad Area in The Netherlands
    Leo H. B. Baur, Timo Lenderink, Cara Lodewijks-van der Bolt, Leo F. Veenstra, Ron A. G. Winkens, (On behalf of the working group on easy access echocardiography in Parkstad) · 2005 · International journal of cardiac imaging
  14. B type natriuretic peptide testing: where are we now?
    Martín Cowie · 2004 · Heart
  15. Heart Failure Prevention and Team-based Interventions
    Paul A. Heidenreich · 2015 · Heart Failure Clinics
  16. Atrial natriuretic peptide predicts disease progression and digital ulcers development in systemic sclerosis patients
    A. Romaniello, Speranza Donatella Rubattu, Antonietta Gigante, Francesca Simonelli, Maria Chiara Grimaldi, Adriano D’Angelo, Danilo Alunni Fegatelli, Lidia Sada, Maria Ludovica Gasperini, Simona Marchitti et al. · 2019 · Journal of Cardiovascular Medicine
  17. Diagnostic and Prognostic Value of N-Terminal Brain Natriuretic Peptide in Patients of Heart Failure
    Ashish Prakash Anjankar, Sandip Deepak Lambe, Kanchan Sandip Lambe · 2020 · Journal of Evolution of Medical and Dental Sciences
  18. B-Type Natriuretic Peptide Is Associated with Indices of Left Ventricular Dysfunction in Healthy Subjects from the General Population: The Akershus Cardiac Examination 1950 Study
    Magnus Nakrem Lyngbakken, Brede Kvisvik, Erika Nerdrum Aagaard, Trygve Berge, Mohammad Osman Pervez, Jon Brynildsen, Arnljot Tveit, Kjetil Steine, Helge Rørvik Røsjø, Torbjørn Omland · 2020 · Clinical Chemistry
  19. Prevalence and Prognostic Value of Heart Failure Stages: An Elderly Inpatient Based Cohort Study
    Pei-Pei Zheng, Si-Min Yao, Di Guo, L. Cui, G. Miao, W. Dong, H. Wang, Jie-Fu Yang · 2021 · Frontiers in Medicine
  20. Screening for ventricular remodeling
    Douglas S. Lee, Thomas J. Wang, Ramachandran Srini Vasan · 2006 · Current Heart Failure Reports
  21. Diagnosis and characterization of left ventricular hypertrophy by computerized acoustic cardiography, brain natriuretic peptide, and electrocardiography
    Robert Kevin Rogers, Sean P. Collins, Michael Christopher Kontos, Michel Züber, Patti Arand, Andrew D. Michaels · 2008 · Journal of Electrocardiology
  22. Validity of Laboratory-based Surveillance for Detection of Respiratory Syncytial Virus Seasons
    Christian Hampp, Nabih R. Asal, Earlene E. Lipowski, Teresa L. Kauf, Eileen Schneider, Paul Scott Kubilis, Almut Gertrud Winterstein · 2013 · American Journal of Epidemiology
  23. Heart failure risk estimation based on novel biomarkers
    Feven Ataklte, Ramachandran Srini Vasan · 2021 · Expert Review of Molecular Diagnostics
  24. Task Force on Practice Guidelines Report of the American College of Cardiology Foundation/American Heart Association 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary: A
    Emily J. Tsai, Bruce Larry Wilkoff, Judith E. Mitchell, Pamela N. Peterson, Barbara J. Riegel, Flora Sam, Edward K. Kasper, Wayne C. Levy, Frederick A. Masoudi, Patrick E. McBride et al. · 2013
  25. Influence of diabetes on natriuretic peptide thresholds in screening for Stage B heart failure
    Chris J Watson, Stephanie James, Eoin O’Connell, Joe Gallagher, James O’Reilly, Elaine Tallon, John Andrew Baugh, Jean O’Connell, Donal Brendan O'Shea, Mark T. Ledwidge et al. · 2016 · Biomarkers
  26. Chronic Heart Failure: We Are Fighting the Battle, but Are We Winning the War?
    John James Atherton · 2012 · Scientifica
  27. Effective Strategies to Improve the Management of Heart Failure
    Geoffrey D. Mills, Christopher V. Chambers · 2012 · Primary Care Clinics in Office Practice
  28. The Dutch experience of open access echocardiography
    Cara Lodewijks-van der Bolt, Leo H. B. Baur, Timo Lenderink, Frank I. Guldemond, J. Nijhof, Ron A. G. Winkens, M. Hundscheid, Jelle Stoffers · 2007 · Netherlands Heart Journal
  29. The diagnostic utility of brain natriuretic peptide in heart failure patients presenting with acute dyspnea: a meta-analysis
    Paolo Mastandrea · 2012 · Clinical Chemistry and Laboratory Medicine (CCLM)
  30. The correlation of ECHO findings of right cardiac pathologies with BNP, uric acid, and CRP in OSAS
    Ömer Araz, Elif Yılmazel Uçar, Hüsnü Değirmenci, Didem Pulur, Hamit Acemoğlu, Ednan Bayram, Fuat Gündoğdu, Metin Akgün · 2014 · TURKISH JOURNAL OF MEDICAL SCIENCES
  31. Comparison of NT-proBNP levels in hemodialysis versus peritoneal dialysis patients
    Ondřej Ludka, Jindřich Špinar, Josef Tomandl, Tomáš Konečný · 2012 · Biomedical Papers
  32. Elevated Level of the Natriuretic Peptide Among Adult Population in Regions Participating in the ESSE-RF Study and Its Association With Cardiovascular Diseases and Risk Factors
    Svetlana Anatolievna Shalnova, А. Э. Имаева, А. Д. Деев, Victoria A. Metelskaya, Муромцева Галина Аркадьевна, А. О. Конради, Valery P. Masenko, А. Yu. Efanov, Н. В. Кулакова, O. P. Rotar et al. · 2017 · Kardiologiia
  33. Biomarkers
    Viorel G. Florea, Inder S. Anand · 2012 · Heart Failure Clinics
  34. The role of natriuretic peptides in heart failure
    Daniel D. Correa de Sa, Horng H. Chen · 2008 · Current Heart Failure Reports
  35. Is echocardiography a valid tool to screen for left ventricular systolic dysfunction in chronic survivors of acute myocardial infarction? A comparison with radionuclide ventriculography
    Gavin I. W. Galasko, S Basu, A Lahiri, R Senior · 2004 · Heart
  36. Comparison of Positive Cases for B-type Natriuretic Peptide and ECG Testing for Identification of Precursor Forms of Heart Failure in an Elderly Population
    Motoyuki Nakamura, Toshiaki Sakai, Masaki Osawa, Toshiyuki Onoda, Shinetsu Yonezawa, Akira Okayama, Katsuhiko Hiramori · 2005 · International Heart Journal
  37. High-density lipoprotein is superior to B-type natriuretic peptide as a marker of systolic dysfunction in an elderly general population
    Tuomas V. Kerola, Tuomo V. M. Nieminen, Sirpa A. Hartikainen, Raimo O. Sulkava, Olli J. Vuolteenaho, Raimo Kettunen · 2009 · Scandinavian Journal of Clinical and Laboratory Investigation
  38. Influence of Atrial Fibrillation on Cardiac Brain Natriuretic Peptide Release During Haemodynamic Stress in Heart Failure
    Paul A. Gould, Joe D’Agostino, Hans Gerhard Schneider, David M. Kaye · 2005 · European Journal of Heart Failure
  39. Update in the Approach to and Management of Heart Failure
    Jill M. Gelow, James Chen-Tson Fang · 2006 · Southern Medical Journal
  40. B-type Natriuretic Peptide for Diagnosis of Heart Failure in Emergency Department Patients: A Critical Appraisal
    Eric Schwam · 2004 · Academic Emergency Medicine
  41. NT-BNP/BNP for screening left ventricular hypertrophy in hypertension: What else?
    Richard Isnard · 2008 · Archives of cardiovascular diseases
  42. Prognostic Value of B-Type Natriuretic Peptide Level in Patients With Heart Failure With a Higher Left Ventricular Ejection Fraction
    Nobuyuki Ohte, Shohei Kikuchi, Noriaki Iwahashi, Yoshiharu Kinugasa, Kaoru Dohi, Hiroyuki Takase, Katsuji Inoue, Takahiro Okumura, Kenta Hachiya, Emiyo Sugiura et al. · 2025 · Circulation Reports
  43. Physician-adherence to pharmacotherapy guidelines for chronic heart failure in a tertiary health facility in Lagos, Nigeria
    Janet N. A. Ajuluchukwu, Anyika Emmanuel, K. Raji · 2013 · Journal of Hospital Administration
  44. NT-proBNP as a predictor of all-cause mortality in a population of insurance applicants.
    Michael Clark, Valerie Kaufman, Michael Fulks, Vera F Dolan, Robert L. Stout · 2014 · PubMed
  45. Aberrant expression of NPPB through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterations
    Tatsuhiro Sato, Ken Akao, Ayuko Sato, Tohru Tsujimura, Satomi Mukai, Yoshitaka Sekido · 2023 · Cancer Medicine
  46. N-terminal pro-atrial natriuretic peptide reflects cardiac remodelling in stage 1 hypertension
    N Partanen, Minna Husso, Olli J. Vuolteenaho, Petri Sipola, Heikki J Ruskoaho, KEIJO J. PEUHKURINEN, Johanna M. Magga · 2011 · Journal of Human Hypertension
  47. Associations between plasma natriuretic peptides and echocardiographic abnormalities in geriatric outpatients
    Joost H.W. Rutten, Nathalie van der Velde, Nathalie van der Velde, Folkert J. ten Cate, Wim B. Vletter, Frans Boomsma, Anton H. van den Meiracker · 2007 · Archives of Gerontology and Geriatrics
  48. Biomarker screening for cardiac dysfunction: The more the merrier?
    W.H. Wilson Tang · 2006 · American Heart Journal
  49. Section 4: Evaluation of Patients for Ventricular Dysfunction and Heart Failure
    Heart Failure Society of America · 2006 · Journal of Cardiac Failure
  50. Heart failure--definition and diagnosis.
    S Ramakrishnan, Kothari Ss, Bahl Vk · 2005 · PubMed
  51. Misconceptions and Facts about Heart Failure with Reduced Ejection Fraction
    Chayakrit Krittanawong, Mario Rodriguez, Matthew Lui, Arunima Misra, W.H. Wilson Tang, Biykem Bozkurt, Clyde W. Yancy · 2023 · The American Journal of Medicine
  52. Sex differences in the diagnostic algorithm of screening for heart failure by symptoms and NT-proBNP in patients with type 2 diabetes
    Sarah Hofer-Zeni, Michael Leutner, Peter Klimek, Luise Bellach, Noémi Pávó, Suriya Prausmüller, Martin Hülsmann, Alexandra Kautzky‐Willer · 2024 · Cardiovascular Diabetology
  53. Calcificación coronaria y disfunción miocárdica subclínica en la artritis reumatoide
    Alberto López de Guzmán, Juan de Dios García-Díaz, M.I. Díez-Pérez de la Vacas, Eduardo Cuende Quintana, Ana Sánchez Atrio, I. Sivera Monzó · 2009 · Revista Clínica Española
  54. Heterogeneity of the prognostic significance of B-type natriuretic peptide levels on admission in patients hospitalized for acute heart failure syndromes
    Yuichiro Minami, Katsuya Kajimoto, Naoki Sato, Nobuhisa Hagiwara, Teruo Takano, Alexandre Mebazaa · 2016 · European Journal of Internal Medicine
  55. Red cell distribution width (RDW) correlates with markers of diastolic dysfunction in patients with impaired left ventricular systolic function
    Fadi T. Alattar, Nashat Imran, Pooja H. Patel, Saad Z. Usmani, Fayez E. Shamoon · 2015 · IJC Heart & Vasculature
  56. B-type natriuretic peptides as powerful markers in cardiac diseases: Analytical and clinical aspects
    Angelika Hammerer‐Lercher, Bernd Puschendorf, Johannes Mair · 2006 · Jugoslovenska medicinska biohemija
  57. Utility of B-type natriuretic peptides and cardiac troponins for population screening regarding cardiac abnormalities
    Kai M. Eggers, Per Venge · 2011 · Pathology
  58. Heart Failure
    John J.V. McMurray, Mark Colquhoun Petrie, Karl B Swedberg, Michel Komajda N, Stefan D. Anker, Roy S. Gardner · 2009
  59. National Academy of Clinical Biochemistry (NACB) laboratory medicine guidelines on the clinical utilization and analytical issues for cardiac biomarker testing in heart failure.
    John P. Beilby · 2008 · PubMed Central
  60. Association of obesity subphenotypes with indices of cardiac remodeling in the Framingham heart study
    William J. He, Brenton R. Prescott, Vanessa Xanthakis, Gary F. Mitchell, Susan C. Cheng, Ramachandran Srini Vasan · 2025 · American Heart Journal
  61. Modulating CGRP Signaling: A Promising Therapeutic Avenue for Attenuating Cardiac Dysfunction in Heart Failure
    Shazia Ansari, Khadga Raj Aran · 2026 · Cardiovascular Drugs and Therapy
  62. Association of biomarkers of cardiac remodeling, myocardial fibrosis and inflammation with parameters of heart function and structure in patients with arterial hypertension
    Táňa Andreasová, Filip Málek, Zuzana Jiraskova Zakostelska, Petr Neužil, Jana Vránová · 2024 · Biomedical Papers
  63. An Artificial Intelligence Algorithm for Early Detection of Left Ventricular Systolic Dysfunction in Patients with Normal Sinus Rhythm
    Seongjin Park, Hyo Jin Lee, Sung‐Hee Song, KyungChang Woo, Jiwon Kim, Juwon Kim, Ju Youn Kim, Seung‐Jung Park, Young Keun On, Kyoung‐Min Park · 2025 · Journal of Clinical Medicine
  64. The Role of Brain Natriuretic Peptide in Population Screening
    Liselotte N. Dyrbye, Margaret M. Redfield · 2003 · Heart Failure Reviews
  65. Addition of N-terminal Pro-B-type Natriuretic Peptide Levels to Electrocardiography Criteria for Detection of Left Ventricular Hypertrophy: The ARIRANG Study
    Min‐Soo Ahn, Byung‐Su Yoo, Ji Hyun Lee, Jun‐Won Lee, Young Jin Youn, Sung Gyun Ahn, Jang‐Young Kim, Seung‐Hwan Lee, Junghan Yoon, Jong-Ku Park et al. · 2015 · Journal of Korean Medical Science
  66. Serum proatrial natriuretic peptide does not increase with higher systolic blood pressure in obese men
    Camilla L Asferg, Ulrik Bjørn Andersen, Allan R Linneberg, Paula Louise Hedley, Michael Christiansen, Jens Peter Goetze, Jørgen Jeppesen · 2016 · Heart
  67. Age‐Specific Impact of Self‐Monitored Pulse Pressure on Hypertensive Target Organ Damage in Treated Hypertensive Patients
    Kazuo Eguchi, Yoshio Matsui, Seiichi Shibasaki, Joji Ishikawa, Satoshi Hoshide, Shizukiyo Ishikawa, Tomoyuki Kabutoya, Joseph E. Schwartz, Thomas G. Pickering, Kazuyuki Shimada et al. · 2007 · Journal of Clinical Hypertension
  68. [Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide].
    Luigi Tarantini, Giovanni Cioffi, Andrea Di Lenarda, Roberto Valle, Giovanni Pulignano, Donatella Del Sindaco, Gianfranco Frigo, Giorgio Soravia, Renato Tessier, Giuseppe Catania · 2008 · PubMed
  69. B-type Natriuretic Peptide (BNP) Is Useful in Detecting Asymptomatic Left Ventricular Dysfunction in Low-Income, Uninsured Patients
    Aurelia Macabasco‐O’Connell, Sheba Meymandi, Robert J. Bryg · 2009 · Biological Research For Nursing
  70. Brain Natriuretic Peptide in Cardiovascular Diseases
    Andreas G. Synetos, Konstantinos A. Aznaouridis, Stamatios Lerakis, Stamatios Lerakis · 2008 · The American Journal of the Medical Sciences
  71. Open access echocardiography is feasible in the Netherlands.
    Leo H. B. Baur, Leo F. Veenstra, T LENDERINK, Cara Lodewijks-van der Bolt, Ron A. G. Winkens, Frank L Soomers, Jelle Stoffers · 2006 · PubMed Central
  72. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients
    Silvio Romano, Stefano Necozione, Leonello Guarracini, Simona Fratini, Pasquale Cisternino, Ferdinando di Orio, Maria Penco · 2009 · Journal of Cardiovascular Medicine
  73. Epidemiology of Heart Failure
    Raghava S. Velagaleti, Ramachandran Srini Vasan · 2010 · Elsevier eBooks
  74. Natriuretic Peptides
    Jacob George, Allan D. Struthers · 2007 · Elsevier eBooks
  75. Biochemical Cardiac Risk Markers in the General Population, Hypertension and Coronary Artery Disease
    Charlotte Kragelund, Caroline Kistorp, Frants Pedersen, Ilan E. Raymond, Per Rossen Hildebrandt · 2005 · Scandinavian Journal of Clinical and Laboratory Investigation
  76. Screening for cardiovascular disease using B-type natriuretic peptides: detecting an imbalance of the four humoursThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.
    David W. Markham, James A. de Lemos · 2005 · European Heart Journal
  77. Natriuretic Peptides in Valvular Heart Diseases
    Arti J Choure, W.H. Wilson Tang, Roger M. Mills · 2006 · Heart Failure Clinics
  78. Structural heart disease screening using artificial intelligence–enabled electrocardiogram and novice handheld cardiac ultrasound: a cost analysis
    Reid P Schlesinger, Francisco B. Alexandrino, Eunjung Lee, Abhishek J. Deshmukh, Vuyisile Tlhopane Nkomo, J K Oh, Peter A. Noseworthy, Patricia A. Pellikka, Zachi Itzhak Attia, Francisco Alejandro López-Jiménez et al. · 2026 · European Heart Journal Open
  79. Natriuretic peptide measurement as a screening test for overt and subclinical heart failure
    Motoyuki Nakamura, Katsuhiko Hiramori · 2003 · International Journal of Cardiology
  80. Multimodal Characterization of Dilated Cardiomyopathy: Geno- and Phenotyping of Primary Cardiomyopathy (GrAPHIC)
    Laura Dorothea Keil, Filip Berisha, Stella Ritter, Johanna Skibowski, Hariharan Subramanian, Viacheslav O. Nikolaev, Christian Kubisch, Rixa Woitschach, Larissa Fabritz, Raphael Twerenbold et al. · 2023 · ESC Heart Failure
  81. Prognostic Significance of B Type Natriuretic Peptide in Acute Coronary Syndrome
    Nasreen Chowdhury, Md Aminul Haque Khan, Md Mozammel Hoque · 2014 · Chattagram Maa-O-Shishu Hospital Medical College Journal
  82. Maximum Longitudinal Relaxation Velocity of the Left Ventricle: Its Clinical Value and Relationship with NT‐proBNP Plasma Levels in Heart Failure
    Raquel Taléns‐Visconti, Miguel Rivera, Vicente E Climent, Ricard Valero, Luis Martínez‐Dolz, M SANCHOTELLO, Raquel Cortés, Vicente Miró, Begoña Sevilla, José Leandro Pérez-Boscá et al. · 2006 · Echocardiography
  83. Are Multiple Biomarker Testing Strategies Ready for Prime Time in Heart Failure?
    Douglas S. Lee, Jack V. Tu · 2009 · Circulation Heart Failure
  84. Section 4: Evaluation of Patients for Ventricular Dysfunction and Heart Failure
    Heart Failure Society of America · 2010 · Journal of Cardiac Failure
  85. Left Ventricular Systolic Dysfunction and Nonischemic Cardiomyopathy
    Karen A. Tarolli · 2003 · Critical Care Nursing Quarterly
  86. Brain Natriuretic Peptide
    Dorothea Tsekoura, Apostolos I. Karavidas, Kostas G. Raisakis, Achilleas Zacharoulis, G. Gennimatas · 2003
  87. Utility of B-type Natriuretic Peptide in Patients with Acute Respiratory Distress Syndrome
    Chin Kook Rhee, Young Bin Joo, Seok Chan Kim, Sung Hak Park, Sook Young Lee, Yoon Seok Koh, Young Kyoon Kim · 2007 · Tuberculosis & respiratory diseases
  88. Natriuretic Peptide Use in Screening in the Community
    Noel S. Lee, Lori B. Daniels · 2016 · Springer eBooks
  89. B-type natriuretic peptide in the cardiology department.
    Paula Mary O’Shea, R Daly, Sazzli Shahlan Kasim, William Patrick Tormey · 2012 · PubMed
  90. Review: The utility of BNP in clinical practice
    Andrew S. P. Sharp, Jamil Mayet · 2004 · Journal of the Renin-Angiotensin-Aldosterone System
  91. Relationship of extent and nature of dysfunctional myocardium to brain natriuretic peptide in patients with ischemic left ventricular dysfunction
    Leo H. B. Baur · 2005 · International journal of cardiac imaging
  92. Brain natriuretic peptide in the contemporary management of congestive heart failure
    Cara A. Wasywich, GILLIAN A. WHALLEY, Robert Neil Doughty · 2005 · Expert Review of Cardiovascular Therapy
  93. Natriuretic peptide testing in primary care patients
    Michele Emdin, Marianna Fontana, Roberta Poletti, Alessandra Gabutti, Chiara Mammini, Andrea Rossi, Luigi Emilio Pastormerlo, Lorenzo Masi, Claudio Passino, Aldo Clerico · 2008 · Clinical Chemistry and Laboratory Medicine (CCLM)
  94. Treatment of asymptomatic left ventricular dysfunction
    George Victor Moukarbel, Scott David Solomon · 2008 · Current Treatment Options in Cardiovascular Medicine
  95. Natriuretic Peptides in Screening for Cardiac Dysfunction
    W.H. Wilson Tang · 2006 · Heart Failure Clinics
  96. The Accuracy of Electrocardiogram Criteria for Left Ventricular Hypertrophy in Korean Cohort (Atherosclerosis Risk of a Rural Area Korean General Population)
    Min‐Soo Ahn, Byung‐Su Yoo, Ji Hyun Lee, Jun‐Won Lee, Young Jin Youn, Sung Gyun Ahn, Jang‐Young Kim, Seung‐Hwan Lee, Junghan Yoon, Kyung‐Hoon Choe et al. · 2013 · Journal of the Korean Society of Hypertension
  97. Comparison between immunoradiometric and fluorimetric brain natriuretic peptide determination in patients with congestive heart failure
    Mauro Feola, Letizia Valeri, Enrica Menditto, Elisabetta Nervo, F. Bianco, Nadia Aspromonte, R. Valle, Gianluca Visconti · 2010 · Journal of Endocrinological Investigation
  98. Change of Body Surface Electrocardiogram is Linked to Left Ventricular Geometric Alteration from Normal, Pre-Hypertension to Hypertension: Comparison of NT-ProBNP and hs-CRP in Determining Ventricular Remodeling
    Chih‐Hsuan Yen, Jui‐Peng Tsai, Yih‐Jer Wu, Jen‐Yuan Kuo, Hung‐I Yeh, Charles Jia‐Yin Hou, Chuanchuan Liu, Chung‐Lieh Hung · 2011 · Zhōnghuá mínguó xīnzàngxué huì zázhì
  99. Age and gender differences in the association between Nt-proBNP and glucometabolic disturbances
    Margrét Leósdóttir, Ronnie B Willenheimer, Christian Hall, Solve Tjora, Johan Malm, Olle Melander, Peter M. Nilsson · 2011 · Scandinavian Cardiovascular Journal
  100. B-Type Natriuretic Peptides in Heart Failure: Update on Clinical Applications and Limitations
    Wayne L. Miller, Paul V. Targonski, Allan S. Jaffe · 2007 · Biomarkers in Medicine